Vaidya Sane (MADHAVBAUG)
Fast GrowerScore breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹148 |
| Market Cap | ₹155.6 Cr |
| P/E Ratio | 25.26 |
| ROCE | 18.45% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 28.46% |
| Debt/Equity | — |
| Sales Growth | 19.47% |
| Promoter Holding | 66.34% |
| 52-Week Range | ₹147 — ₹335 |
| Sector | Healthcare Equipment & Supplies |
Strengths
- Sales growth of 19.47% and profit growth of 28.46% show strong compounding momentum
- ROCE of 18.45% indicates good capital efficiency
- Piotroski F-Score of 7/9 points to sound financial health
- Promoter holding of 66.34% aligns management with minority shareholders
Concerns
- P/E of 25.26 with zero dividend means the entire return depends on price appreciation
- Book value, ROE, and debt/equity data are missing, limiting fundamental analysis
- Stock at ₹195 is roughly 42% below its 52-week high of ₹335, suggesting possible market skepticism
- Latest quarter shows ₹50 Cr sales and ₹5 Cr profit, indicating a small scale that needs consistency
AI Analysis
When I look at Vaidya Sane, the first thing I see is a business with momentum but not enough evidence to call it a wonderful company at a fair price. Sales grew nearly 20% and profits 28% — that is impressive. ROCE of 18.45% suggests the management is putting capital to decent use, and a Piotroski score of 7 out of 9 indicates a fundamentally sound financial position. The promoter holding of 66.34% aligns management with shareholders, which I always respect. But Graham would demand a margin of safety. At ₹195, I am paying 25.26 times earnings for a company whose book value, return on equity, and debt position are not disclosed in the data I have. That troubles me. I cannot value what I cannot measure. The absence of dividend also means my only return comes from price appreciation, and with the stock trading well below its 52-week high of ₹335, there is a chance the market is already questioning the story. The latest quarter shows sales of ₹50 Cr and profit of ₹5 Cr, a 10% net margin, confirming profitability at a small scale. The PEG ratio around 1.05 suggests the earnings growth is roughly in line with the multiple, so it is not obviously cheap. If the growth rate is real and sustainable, this could be a fast grower worth watching. But I prefer businesses where I can see the balance sheet, understand the debt, and calculate a conservative intrinsic value. This one remains incomplete. I would keep it on my watchlist, not in my portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer